Quick Answer
Outset Medical, Inc. reported R&D Expense of $21.23 million for fiscal year 2025.
Outset Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $21.23M | -44.7% |
| 2024 | $38.40M | -33.0% |
| 2023 | $57.31M | +17.3% |
| 2022 | $48.85M | +33.0% |
| 2021 | $36.74M | +27.4% |
| 2020 | $28.85M | +23.7% |
| 2019 | $23.33M | +1.8% |
| 2018 | $22.92M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.38M | -33.9% | +1.6% |
| June 30, 2025 | $5.29M | -45.7% | -4.1% |
| March 31, 2025 | $5.51M | -56.4% | -32.2% |
| September 30, 2024 | $8.14M | -49.4% | -16.4% |
| June 30, 2024 | $9.73M | -34.7% | -23.0% |
| March 31, 2024 | $12.63M | -8.4% | -21.4% |
| September 30, 2023 | $16.08M | +23.1% | +7.8% |
| June 30, 2023 | $14.91M | +10.2% | +8.1% |
- Outset Medical, Inc. showed a decrease of -44.7% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, Outset Medical, Inc.’s r&d expense has declined by 7.3% (from $22.92 million to $21.23 million).
- The most recent figure is from Outset Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: